Inventor · disambiguated record
Riccardo Cortese
Also filed as: CORTESE RICCARDO · CORTESE SR RICCARDO
24 granted patents·13 pending applications·156 citations·filing 1994–2023
94Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA12ANGELETTI P IST RICHERCHE BIO5ISTITUTO DI RECERCHE DI BIOLOG2US GOV HEALTH & HUMAN SERVICES2COLLOCA STEFANO1
Top patents by PatentIndex Score
37 records- 0190US9718863B2Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofCOLLOCA STEFANO·Filed 2010·Granted Aug 1, 2017·19 cites·14 claims
- 0289US10544192B2Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 28, 2020·8 cites·3 claims
- 0388US9526777B2Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoproteinSULLIVAN NANCY J·Filed 2011·Granted Dec 27, 2016·7 cites·5 claims
- 0486US7598362B2Hepatitis C virus vaccineMERCK & CO INC·Filed 2002·Granted Oct 6, 2009·12 cites·50 claims
- 0583US11254710B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·2 cites·12 claims
- 0680US2024075125A1Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 0778US10576143B2Poxviral vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Mar 3, 2020·1 cites·12 claims
- 0876US11913013B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2021·Granted Feb 27, 2024·0 cites·5 claims
- 0974US11214599B2Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jan 4, 2022·0 cites·17 claims
- 1074US2022220157A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1173US6265169B1Method based on the use of bacteriophages for the detection biological molecules in biological samplesANGELETTI P IST RICHERCHE BIO·Filed 1998·Granted Jul 24, 2001·41 cites·14 claims
- 1273US5994083AProcess for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainableISTITUTO DI RECERCHE DI BIOLOG·Filed 1994·Granted Nov 30, 1999·45 cites·8 claims
- 1373US2022204566A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1470US9895431B1Simian adenoviral vectors encoding malaria antigenREYES ARTURO·Filed 2008·Granted Feb 20, 2018·2 cites·7 claims
- 1570US8142794B2Hepatitis C virus vaccineEMINI EMILIO A·Filed 2009·Granted Mar 27, 2012·1 cites·27 claims
- 1669US11701422B2Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Jul 18, 2023·0 cites·16 claims
- 1769US11278614B2Poxviral vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Mar 22, 2022·0 cites·7 claims
- 1867US2020149069A1Chimpanzee adenoviral vector-based filovirus vaccinesTHE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF·Filed 2020·Application pending·0 cites
- 1965US2021060150A1Novel adenovirusGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2064US10584355B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2016·Granted Mar 10, 2020·0 cites·16 claims
- 2164US6706261B1Compositions and methods comprising immunogenic muteins of interleukin-6ANGELETTI P IST RICHERCHE BIO·Filed 2000·Granted Mar 16, 2004·2 cites·12 claims
- 2261US11254711B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 2357US2016000904A1Improved poxviral vaccinesGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Application pending·0 cites
- 2454US6528061B1Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositionsPASTEUR INSTITUT·Filed 1998·Granted Mar 4, 2003·16 cites·2 claims
- 2554US2007259959A1Ppar Agonists for the Treatment of Hcv InfectionCORTESE RICCARDO·Filed 2004·Application pending·0 cites
- 2653US2014141042A1Expression SystemsVITELLI ALESSANDRA·Filed 2011·Application pending·0 cites
- 2752US10588961B2Poxviral vaccinesGLAXOSMITHLKINE BIOLOGICALS SA·Filed 2017·Granted Mar 17, 2020·0 cites·12 claims
- 2852US2011129498A1Vaccine for the prevention and therapy of hcv infectionsOKAIROS AG·Filed 2009·Application pending·0 cites
- 2948US6960558B2Method of screening for anti-obesity agents using ciliary neutrophic factor receptorANGELETTI P IST RICHERCHE BIO·Filed 2003·Granted Nov 1, 2005·0 cites·4 claims
- 3042US2003124143A1Methods for selecting immunogenic polypeptidesFiled 2002·Application pending·0 cites
- 3141US7928193B2Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replicationANGELETTI P IST RICHERCHE BIO·Filed 2005·Granted Apr 19, 2011·0 cites·6 claims
- 3239US2003109678A1Methods and means for regulation of gene expressionFiled 2001·Application pending·0 cites
- 3336US2005019751A1Screening for hepatitis c virus entry inhibitorsFiled 2002·Application pending·0 cites
- 3435US11498956B2Fusion peptides with antigens linked to short fragments of invariant chain(CD74)GLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Nov 15, 2022·0 cites·19 claims
- 3533US2013150563A1Lipid-conjugated antibodiesPESSI ANTONELLO·Filed 2011·Application pending·0 cites
- 3627US7034108B1Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereofANGELETTI P IST RICHERCHE BIO·Filed 1999·Granted Apr 25, 2006·0 cites·6 claims
- 3727US6541210B1Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainableISTITUTO DI RECERCHE DI BIOLOG·Filed 1999·Granted Apr 1, 2003·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Riccardo Cortese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →